Stakeholder Views on Pharmacogenomic Testing

A Randomized and Clinical Effectiveness Trial Comparing Two Pharmacogenetic Algorithms and Standard Care for Individualizing Warfarin Dosing (CoumaGen-II)

(2012) Jeffrey L. Anderson et al.   CIRCULATION

Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testing

(2012) SB Haga et al.   CLINICAL GENETICS

Primary care physicians' knowledge of and experience with pharmacogenetic testing

(2012) SB Haga et al.   CLINICAL GENETICS

Clinical and economic challenges facing pharmacogenomics

(2012) J Cohen et al.   PHARMACOGENOMICS JOURNAL

Professional Perspectives About Pharmacogenetic Testing and Managing Ancillary Findings

(2011) Susanne B. Haga et al.   Genetic Testing and Molecular Biomarkers

Public Perspectives About Pharmacogenetic Testing and Managing Ancillary Findings

(2011) Susanne B. Haga et al.   Genetic Testing and Molecular Biomarkers

Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions

(2011) Susanne B. Haga et al.   GENETICS IN MEDICINE

Consideration of patient preferences and challenges in storage and access of pharmacogenetic test results

(2011) Susanne B. Haga et al.   GENETICS IN MEDICINE

Personalizing medicine with clinical pharmacogenetics

(2011) Stuart A. Scott   GENETICS IN MEDICINE

Provision of personalized genomic diagnostic technologies for breast and colorectal cancer: an analysis of patient needs, expectations and priorities

(2011) Amalia M Issa et al.   Personalized Medicine

Survey of US public attitudes toward pharmacogenetic testing

(2011) S B Haga et al.   PHARMACOGENOMICS JOURNAL

Communicating Pharmacogenetic Research Results to Breastfeeding Mothers Taking Codeine: A Pilot Study of Perceptions and Benefits

(2010) P Madadi et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Clinical and Ethical Considerations in Pharmacogenetic Testing

(2010) Jinger G. Hoop et al.   JOURNAL OF CLINICAL PSYCHIATRY

Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice

(2010) Alessio Squassina et al.   PHARMACOGENOMICS

Racial Differences in Parents' Distrust of Medicine and Research

(2009) Kumaravel Rajakumar et al.   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Public involvement in pharmacogenomics research: a national survey on public attitudes towards pharmacogenomics research and the willingness to donate DNA samples to a DNA bank in Japan

(2009) Eriko Kobayashi et al.   CELL AND TISSUE BANKING

Public involvement in pharmacogenomics research: a national survey on patients’ attitudes towards pharmacogenomics research and the willingness to donate DNA samples to a DNA bank in Japan

(2009) Eriko Kobayashi et al.   CELL AND TISSUE BANKING

Survey on warfarin pharmacogenetic testing among anticoagulation providers

(2009) Maha Kadafour et al.   PHARMACOGENOMICS

Assessing Patient Readiness for the Clinical Adoption of Personalized Medicine

(2009) A.M. Issa et al.   Public Health Genomics

Researchers’ Perceptions of the Ethical Implications of Pharmacogenomics Research with Children

(2009) D. Avard et al.   Public Health Genomics

Views on Personalized Medicine: Do the Attitudes of African American and White Prescription Drug Consumers Differ?

(2009) M. De Marco   Public Health Genomics

Factors Influencing Uptake of Pharmacogenetic Testing in a Diverse Patient Population

(2009) J. O’Daniel et al.   Public Health Genomics

Pharmacogenetic testing: not as simple as it seems

(2008) Susanne B Haga et al.   GENETICS IN MEDICINE

Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use

(2008) Felix W Frueh et al.   PHARMACOTHERAPY

Is the UK public ready for genetic medicine?

(2007) Peter Finegold et al.   Personalized Medicine